Evidence map›Paper›PMID 35750302›Full record

ArticleInternational journal of cardiology2022

The impact of the COVID-19 pandemic on heart failure management: Global experience of the OPTIMIZE Heart Failure Care network.

Martin R Cowie, Ricardo Mourilhe-Rocha, Hung-Yu Chang, Maurizio Volterrani, Ha Ngoc Ban, Denilson Campos de Albuquerque, Edward Chung, Cândida Fonseca, Yuri Lopatin, José Antonio Magaña Serrano and 11 more

Abstract read
In one paragraph

Article in International journal of cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Martin R CowieRoyal Brompton Hospital, Guy's & St Thomas' NHS Foundation Trust, and School of Cardiovascular Medicine and Sciences, Faculty of Lifesciences & Medicine, King's College London, London, UK. Electronic address: martin.cowie@kcl.ac.uk.
Ricardo Mourilhe-RochaPedro Ernesto University Hospital, Rio de Janeiro State University, Rio de Janeiro, RJ, Brazil; Hospital Pró-Cardíaco, Rio de Janeiro, RJ, Brazil.
Hung-Yu ChangHeart Center, Cheng Hsin General Hospital, and Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Maurizio VolterraniDepartment of Cardiovascular and Respiratory Sciences, Scientific Institute for Research, Hospitalization and Health Care (IRCCS) San Raffaele Roma, Rome, Italy.
Ha Ngoc BanHo Chi Minh City Heart Institute, Ho Chi Minh City, Viet Nam.
Denilson Campos de AlbuquerquePedro Ernesto University Hospital, Rio de Janeiro State University, Rio de Janeiro, RJ, Brazil.
Edward ChungDepartment of Medicine, University of the West Indies, Mona, Jamaica.
Cândida FonsecaHeart Failure Clinic, Department of Internal Medicine, São Francisco Xavier Hospital, and NOVA Medical School, Faculty of Medical Sciences, NOVA University, Lisbon, Portugal.
Yuri LopatinRegional Cardiology Centre, Volgograd State Medical University, Volgograd, Russian Federation.
José Antonio Magaña SerranoDivision of Heart Failure and Cardiac Transplantation, Cardiology Hospital, National Medical Center "Siglo XXI", Mexican Social Security Institute, Mexico City, Mexico.
Lilyana MirchevaSecond Cardiology Clinic, University Hospital St. Marina, and First Department of Internal Medicine, Medical University of Varna, Varna, Bulgaria.
Gustavo Adolfo Moncada-PazDepartment of Cardiology, Honduran Social Security Institute, and Faculty of Medical Sciences, National Autonomous University of Honduras, Tegucigalpa, Honduras.
Zurab PagavaBokhua Memorial Cardiovascular Center, Tbilisi, Georgia.
Eugenio B ReyesPhilippine General Hospital and Division of Cardiovascular Medicine, University of the Philippines, Manila, Philippines.
Clara SaldarriagaDepartment of Cardiology, Pontifical Bolivarian University and University of Antioquia, Medellín, Colombia.
Pedro SchwartzmannUnimed Hospital Ribeirão Preto and Advanced Center for Research, Teaching and Diagnosis, Ribeirão Preto, SP, Brazil.
David Sim Kheng LengDepartment of Cardiology, National Heart Centre Singapore, Singapore.
Marcelo TriviDepartment of Clinical Cardiology, Buenos Aires Cardiovascular Institute, Buenos Aires, Argentina.
Yoto Trifonov YotovSecond Cardiology Clinic, University Hospital St. Marina, and First Department of Internal Medicine, Medical University of Varna, Varna, Bulgaria.
Shelley ZierothHeart Failure and Transplant Clinics, St. Boniface Hospital, and Section of Cardiology, University of Manitoba, Winnipeg, MB, Canada.
OPTIMIZE Heart Failure Care program coordinators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the COVID-19 pandemic, reductions in heart failure (HF) hospitalizations have been widely reported, and there is an urgent need to understand how HF care has been reorganized in countries with different infection levels, vaccination rates and healthcare services. The OPTIMIZE Heart Failure Care program has a global network of investigators in 42 countries, with first-hand experience of the impact of the pandemic on HF management in different care settings. The national coordinators were surveyed to assess: 1) the challenges of the COVID-19 pandemic for continuity of HF care, from both a hospital and patient perspective; 2) the organizational changes enacted to ensure continued HF care; and 3) lessons learned for the future of HF care. Contributions were obtained from 37 national coordinators in 29 countries. We summarize their input, highlighting the issues raised and using the example of three very different settings (Italy, Brazil, and Taiwan) to illustrate the similarities and differences across the OPTIMIZE program.

Indexed as

COVID-19Heart FailureBrazilHumansPandemicsSurveys and QuestionnairesContinuity of careCOVID-19Heart failurePandemicTelemedicine

Identifiers

PMID35750302
PMCPMC9217066

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.